NCT07441707 2026-03-02
A Study to Assess a Medicine Called Tovorafenib in Japanese Children and Young Adults With Brain Tumours
Ipsen
Phase 1 Not yet recruiting
Ipsen
Dana-Farber Cancer Institute
Day One Biopharmaceuticals, Inc.
Beijing Sanbo Brain Hospital